Undetected Bacterial Involvement and Antibiotic Efficacy in Nonbacterial CP/CPPS

Overview

This prospective study investigated the presence of bacteria undetectable by standard culture in men with CP/CPPS and evaluated the efficacy of targeted antibiotic treatment. PCR testing identified pathogens in some patients classified as nonbacterial CP/CPPS, and antibiotic therapy led to symptom improvement in those with detected bacteria.

Background

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is a common condition characterized by pelvic pain without detectable uropathogenic bacteria by conventional methods. Its etiology remains unclear, with hypotheses including infections, autoimmune factors, and pelvic muscle dysfunction. Despite frequent empirical antibiotic use, the role of undetected bacteria in CP/CPPS pathogenesis is uncertain. Molecular techniques such as PCR may reveal hidden pathogens, potentially guiding more effective treatment strategies.

Data Highlights

Patients with suspected CP/CPPS symptoms for ≥6 months underwent urine and expressed prostatic secretion testing via culture and PCR for Mycoplasma hominis, Myc. genitalium, Ureaplasma parvum, and U. urealyticum. Those with bacterial counts ≥10³ CFU/mL or PCR positivity received targeted antibiotics for ~6 weeks. Symptom scores (NIH-CPSI, IPSS, OABSS) were assessed before and up to 3 months post-treatment to evaluate efficacy.

Key Findings

• Standard bacterial cultures often failed to detect pathogens in CP/CPPS patients, but PCR identified Mycoplasma and Ureaplasma species in some cases.
• Patients positive for bacteria by PCR or culture who received antibiotics showed significant symptom improvement compared to those without detected bacteria receiving symptomatic treatment.
• Mycoplasma genitalium was detected in six patients, with 23S rRNA gene sequencing performed to identify potential resistance mutations.
• Symptom assessment tools (NIH-CPSI, IPSS, OABSS) demonstrated measurable improvement following targeted antibiotic therapy.
• Findings support the hypothesis that occult bacterial infection may contribute to CP/CPPS pathophysiology in a subset of patients.

Clinical Implications

Clinicians should consider molecular diagnostic methods such as PCR to detect hidden bacterial pathogens in patients with CP/CPPS who test negative by standard culture. Targeted antibiotic therapy based on PCR results may improve symptoms in these patients. This approach could refine treatment strategies beyond empirical antibiotic use and symptomatic management.

Conclusion

The study highlights the potential role of undetected bacterial infections in CP/CPPS and supports the use of molecular diagnostics to guide effective antibiotic treatment. Incorporating PCR testing may enhance patient outcomes by identifying treatable infections otherwise missed by conventional methods.

References

1. NIH Classification of Prostatitis -- NIH, 1999
2. UPOINTS Classification and CP/CPPS Management -- Shoskes et al., 2009
3. PCR Detection of Mycoplasma and Ureaplasma in Prostatitis -- Jensen et al., 2004